Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PHARMASSET INC Financial Overview

  • Income Statement: VRUS

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 1.86 M 22.01 M -20.15 M -1,085.11%
    Gross Profit 861,921.00 21.12 M -20.26 M -2,350.00%
    Net Income Before Extra Items/Preferred Div -54.66 M -5.06 M -49.59 M 90.73%
    Operating Income -54.43 M -7.52 M -46.91 M 86.18%
  • Cash Flow: VRUS

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 46.55 M 42.07 M 4.48 M 9.62%
    Net Cash Flow - Investing 150,199.00 437,010.00 -286,811.00 -190.95%
    Net Cash Flow/Operating Activities -52.07 M 927,155.00 -53.00 M 101.78%
  • Balance Sheet: VRUS

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 68.98 M 75.84 M -6.86 M -9.95%
    Total Liabilities 33.79 M 16.91 M 16.89 M 49.97%
    Shareholders Equity 35.19 M 58.94 M -23.75 M -67.49%
  • Key Ratios / Statistics: VRUS

    • Valuation

      Price/Earnings (TTM) -4.86
      Price/Sales (TTM) 153.95
      Price/Book (MRQ) 6.23
      Price/Cash Flow (TTM) -10.61
    • Profitability

      Gross Margin 46.41
      Operating Margin -2,930.68
      Profit Margin -2,943.07
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 4.86
      Current Ratio (MRQ) 3.95
      Long Term Debt-to-Equity (MRQ) 33.86
    • Management Effectiveness

      Return on Equity (TTM) -176.93
      Return on Assets (TTM) -79.20
      Return on Investments (TTM) -93.74